TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis: A Phase II Randomized Placebo Controlled Trial
Brief Summary: Benralizumab will be used in a placebo controlled randomized study to treat severe chronic rhinosinusitis with nasal polyps


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Reslizumab 3.0 mg/kg; Type: EXPERIMENTAL; Interventions: Drug: Reslizumab | Intervention Type: DRUG; Name: Reslizumab; Assigned to Arm(s): Reslizumab 3.0 mg/kg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (for dupilumab), Drug: Mometasone furoate nasal spray | Arm Label: Dupilumab 300 mg QW; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Drug: Mometasone furoate nasal spray | Intervention Type: DRUG; Name: Placebo (for dupilumab); Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Dupilumab; Assigned to Arm(s): Dupilumab 300 mg QW | Intervention Type: DRUG; Name: Mometasone furoate nasal spray; Assigned to Arm(s): Dupilumab 300 mg QW, Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Mometasone furoate 50 micrograms | Arm Label: Dupilumab 300 mg; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab SAR231893 (REGN668), Drug: Mometasone furoate 50 micrograms | Intervention Type: DRUG; Name: Dupilumab SAR231893 (REGN668); Assigned to Arm(s): Dupilumab 300 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Mometasone furoate 50 micrograms; Assigned to Arm(s): Dupilumab 300 mg, Placebo
D: Arm Label: Benralizumab treatment group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Benralizumab | Arm Label: Placebo group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Benralizumab; Assigned to Arm(s): Benralizumab treatment group | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Optokinetic Stimulation for the Treatment of Hemispatial Neglect - Safety and Efficacy Studies
Brief Summary: Hemispatial neglect is a disorder where the patient has difficulty attending to objects and information in the left side of space, which occurs following strokes to the right side of the brain. This project is designed to help us understand how optokinetic stimulation treats the symptoms of hemispatial neglect.


Options:
A: Arm Label: Action Training; Type: ACTIVE_COMPARATOR; Interventions: Other: Action Training | Arm Label: tDCS; Type: EXPERIMENTAL; Interventions: Other: Transcranial direct current stimulation | Arm Label: Action Training + tDCs; Type: EXPERIMENTAL; Interventions: Other: Transcranial direct current stimulation, Other: Action Training | Arm Label: Control training; Type: PLACEBO_COMPARATOR; Interventions: N/A | Intervention Type: OTHER; Name: Transcranial direct current stimulation; Assigned to Arm(s): Action Training + tDCs, tDCS | Intervention Type: OTHER; Name: Action Training; Assigned to Arm(s): Action Training, Action Training + tDCs
B: Arm Label: Mirror therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Mirror therapy | Arm Label: Sham mirror; Type: SHAM_COMPARATOR; Interventions: Behavioral: Sham mirror | Arm Label: Covered mirror; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Covered mirror | Intervention Type: BEHAVIORAL; Name: Mirror therapy; Assigned to Arm(s): Mirror therapy | Intervention Type: BEHAVIORAL; Name: Sham mirror; Assigned to Arm(s): Sham mirror | Intervention Type: BEHAVIORAL; Name: Covered mirror; Assigned to Arm(s): Covered mirror
C: Arm Label: Optimization of OKS; Type: EXPERIMENTAL; Interventions: Device: OKS | Arm Label: Safety and efficacy study; Type: EXPERIMENTAL; Interventions: Device: OKS | Arm Label: Effect of repetitive stimulation; Type: EXPERIMENTAL; Interventions: Device: OKS | Arm Label: OKS and gait; Type: EXPERIMENTAL; Interventions: Device: OKS | Intervention Type: DEVICE; Name: OKS; Assigned to Arm(s): Effect of repetitive stimulation, OKS and gait, Optimization of OKS, Safety and efficacy study
D: Arm Label: Prism adaptation treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Prism Goggles | Arm Label: Sham prism adaptation treatment; Type: SHAM_COMPARATOR; Interventions: Other: Non-Shifting Goggles | Intervention Type: BEHAVIORAL; Name: Prism Goggles; Assigned to Arm(s): Prism adaptation treatment | Intervention Type: OTHER; Name: Non-Shifting Goggles; Assigned to Arm(s): Sham prism adaptation treatment

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clinical Outcomes of a Nationwide, Naturalistic E-Cig Trial (CONNECT)
Brief Summary: The purpose of this study is to measure changes in smoking behavior during and following sampling of an e-cigarette product. E-cigarettes are classified by the US Food and Drug Administration (FDA) as a tobacco product, though they contain no tobacco. Unlike regular cigarettes, which are burned (creating smoke that is inhaled), e-cigarettes include a heating element that vaporizes nicotine. E-cigarettes are likely much safer than conventional cigarettes, but they may not be entirely safe. We are testing the effects of one specific ecigarette (NJoy) on naturalistic changes in smoking behavior. Neither the tobacco industry nor any ecigarette manufacturer provides support of any kind to this study. There is no requirement to quit smoking in this study, nor is there any requirement to use e-cigarettes.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Extended IVR (integrated voice response technology), Drug: Varenicline (Champix), Behavioral: IVR treatment | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline (Champix), Behavioral: IVR treatment | Intervention Type: BEHAVIORAL; Name: Extended IVR (integrated voice response technology); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Varenicline (Champix); Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: IVR treatment; Assigned to Arm(s): 1, 2
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Sampling; Type: EXPERIMENTAL; Interventions: Behavioral: Electronic Cigarette | Intervention Type: BEHAVIORAL; Name: Electronic Cigarette; Assigned to Arm(s): Sampling
C: Arm Label: Order 1; Type: EXPERIMENTAL; Interventions: Drug: Nicotine Nasal Spray, Drug: Varenicline, Drug: Placebo Nasal Spray, Drug: Placebo Varenicline | Arm Label: Order 2; Type: EXPERIMENTAL; Interventions: Drug: Nicotine Nasal Spray, Drug: Varenicline, Drug: Placebo Nasal Spray, Drug: Placebo Varenicline | Arm Label: Order 3; Type: EXPERIMENTAL; Interventions: Drug: Nicotine Nasal Spray, Drug: Varenicline, Drug: Placebo Nasal Spray, Drug: Placebo Varenicline | Arm Label: Order 4; Type: EXPERIMENTAL; Interventions: Drug: Nicotine Nasal Spray, Drug: Varenicline, Drug: Placebo Nasal Spray, Drug: Placebo Varenicline | Intervention Type: DRUG; Name: Nicotine Nasal Spray; Assigned to Arm(s): Order 1, Order 2, Order 3, Order 4 | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Order 1, Order 2, Order 3, Order 4 | Intervention Type: DRUG; Name: Placebo Nasal Spray; Assigned to Arm(s): Order 1, Order 2, Order 3, Order 4 | Intervention Type: DRUG; Name: Placebo Varenicline; Assigned to Arm(s): Order 1, Order 2, Order 3, Order 4
D: Intervention Type: DRUG; Name: CP-526,555 (varenicline); Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Music Intervention for Agitation Reduction in the Pediatric Intensive Care Unit
Brief Summary: The objective of this study is to administer music therapy to patients in the pediatric intensive care unit (PICU) in order to observe how music affects patient agitation, vital signs, and overall recovery in the unit.


Options:
A: Arm Label: Dynamic light; Type: EXPERIMENTAL; Interventions: Other: Dynamic Light | Arm Label: Normal Light; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Dynamic Light; Assigned to Arm(s): Dynamic light
B: Arm Label: Acupuncture; Type: EXPERIMENTAL; Interventions: Device: acupuncture | Arm Label: Sham Acupuncture; Type: SHAM_COMPARATOR; Interventions: Device: sham acupuncture | Intervention Type: DEVICE; Name: acupuncture; Assigned to Arm(s): Acupuncture | Intervention Type: DEVICE; Name: sham acupuncture; Assigned to Arm(s): Sham Acupuncture
C: Arm Label: Interventional; Type: EXPERIMENTAL; Interventions: Other: Music Therapy | Arm Label: Comparison; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Music Therapy; Assigned to Arm(s): Interventional
D: Arm Label: Comfort Care; Type: EXPERIMENTAL; Interventions: Other: Comfort Care | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Intervention Type: OTHER; Name: Comfort Care; Assigned to Arm(s): Comfort Care | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual Care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Follow-up of Patients Treated in VeClose Study (Five Years)
Brief Summary: The VeClose Five Year Follow-up Extension Study will seek to gain additional follow-up data from the patients enrolled in the VeClose study (NCT01807585).


Options:
A: Arm Label: Surgery; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surgery - Saphenofemoral ligation, saphenous strip and avulsions | Arm Label: EVLT; Type: EXPERIMENTAL; Interventions: Procedure: EVLT | Intervention Type: PROCEDURE; Name: Surgery - Saphenofemoral ligation, saphenous strip and avulsions; Assigned to Arm(s): Surgery | Intervention Type: PROCEDURE; Name: EVLT; Assigned to Arm(s): EVLT
B: Arm Label: Experimental: VenaSeal SCS; Type: N/A; Interventions: Device: VenaSeal SCS | Arm Label: Active Comparator: RFA; Type: N/A; Interventions: Device: ClosureFast Radiofrequency Ablation (RFA) | Arm Label: Experimental: Roll-in (VenaSeal SCS); Type: N/A; Interventions: Device: Roll-In (VenaSeal SCS) | Intervention Type: DEVICE; Name: VenaSeal SCS; Assigned to Arm(s): Experimental: VenaSeal SCS | Intervention Type: DEVICE; Name: ClosureFast Radiofrequency Ablation (RFA); Assigned to Arm(s): Active Comparator: RFA | Intervention Type: DEVICE; Name: Roll-In (VenaSeal SCS); Assigned to Arm(s): Experimental: Roll-in (VenaSeal SCS)
C: Arm Label: EndoVenous Laser Ablation; Type: ACTIVE_COMPARATOR; Interventions: Device: EVLA, Drug: Lidocaine with 1:200,000 epinephrine solution, Drug: Sodium Bicarbonate | Arm Label: MechanoChemical Ablation (ClariVein®); Type: ACTIVE_COMPARATOR; Interventions: Device: ClariVein®, Drug: Lidocaine with 1:200,000 epinephrine solution, Drug: Sodium Tetradecyl Sulphate | Intervention Type: DEVICE; Name: EVLA; Assigned to Arm(s): EndoVenous Laser Ablation | Intervention Type: DEVICE; Name: ClariVein®; Assigned to Arm(s): MechanoChemical Ablation (ClariVein®) | Intervention Type: DRUG; Name: Lidocaine with 1:200,000 epinephrine solution; Assigned to Arm(s): EndoVenous Laser Ablation, MechanoChemical Ablation (ClariVein®) | Intervention Type: DRUG; Name: Lidocaine with 1:200,000 epinephrine solution; Assigned to Arm(s): EndoVenous Laser Ablation | Intervention Type: DRUG; Name: Sodium Bicarbonate; Assigned to Arm(s): EndoVenous Laser Ablation | Intervention Type: DRUG; Name: Sodium Tetradecyl Sulphate; Assigned to Arm(s): MechanoChemical Ablation (ClariVein®)
D: Arm Label: Radiofrequency treatment; Type: EXPERIMENTAL; Interventions: Procedure: Radiofrequency ablation, Procedure: Multilayer Compressive Bandage | Arm Label: Multilayer Compressive Bandage only; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Multilayer Compressive Bandage | Intervention Type: PROCEDURE; Name: Radiofrequency ablation; Assigned to Arm(s): Radiofrequency treatment | Intervention Type: PROCEDURE; Name: Multilayer Compressive Bandage; Assigned to Arm(s): Multilayer Compressive Bandage only, Radiofrequency treatment

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Follow-up of Patients Treated in VeClose Study (Five Years)
Brief Summary: The VeClose Five Year Follow-up Extension Study will seek to gain additional follow-up data from the patients enrolled in the VeClose study (NCT01807585).


Options:
A: Arm Label: Endovenous laser ablation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Endovenous laser ablation with 940 nm bare fiber | Arm Label: Endovenous steam ablation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Endovenous steam ablation with steam vein sclerosis system. | Intervention Type: PROCEDURE; Name: Endovenous laser ablation with 940 nm bare fiber; Assigned to Arm(s): Endovenous laser ablation | Intervention Type: PROCEDURE; Name: Endovenous steam ablation with steam vein sclerosis system.; Assigned to Arm(s): Endovenous steam ablation
B: Arm Label: CE Marked Sapheon Closure System in GSV; Type: EXPERIMENTAL; Interventions: Device: CE Marked Sapheon Closure System | Intervention Type: DEVICE; Name: CE Marked Sapheon Closure System; Assigned to Arm(s): CE Marked Sapheon Closure System in GSV
C: Arm Label: High ligation and stripping (surgery); Type: N/A; Interventions: N/A | Arm Label: Foam sclerotherapy; Type: N/A; Interventions: N/A
D: Arm Label: Experimental: VenaSeal SCS; Type: N/A; Interventions: Device: VenaSeal SCS | Arm Label: Active Comparator: RFA; Type: N/A; Interventions: Device: ClosureFast Radiofrequency Ablation (RFA) | Arm Label: Experimental: Roll-in (VenaSeal SCS); Type: N/A; Interventions: Device: Roll-In (VenaSeal SCS) | Intervention Type: DEVICE; Name: VenaSeal SCS; Assigned to Arm(s): Experimental: VenaSeal SCS | Intervention Type: DEVICE; Name: ClosureFast Radiofrequency Ablation (RFA); Assigned to Arm(s): Active Comparator: RFA | Intervention Type: DEVICE; Name: Roll-In (VenaSeal SCS); Assigned to Arm(s): Experimental: Roll-in (VenaSeal SCS)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lower Protein Intake and Long-term Risk of Obesity and Cardiovascular Disease: A Multi-centred, Randomised, Controlled Trial
Brief Summary: The primary objective of this study is to investigate if consumption of lower protein formula can slow the rate of weight gain of formula-fed infants between 3 and 12 months of age. Secondary objectives include investigation into whether infant nutrition and growth have an impact on later risk of obesity and cardiovascular disease.


Options:
A: Arm Label: Breast Fed reference group; Type: N/A; Interventions: N/A | Arm Label: Infant formula - protein level 1; Type: N/A; Interventions: N/A | Arm Label: Infant formula - protein level 2; Type: N/A; Interventions: N/A
B: Arm Label: Standard infant formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Standard infant formula | Arm Label: Protein reduced formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Protein reduced alpha-lactalbumin formula, with higher levels of alpha-lactalbumin | Arm Label: Breast-feeding; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Standard infant formula; Assigned to Arm(s): Standard infant formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Protein reduced alpha-lactalbumin formula, with higher levels of alpha-lactalbumin; Assigned to Arm(s): Protein reduced formula
C: Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Other: Modified infant formula | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard infant formula | Arm Label: Breast-fed Reference Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Modified infant formula; Assigned to Arm(s): Experimental Group | Intervention Type: OTHER; Name: Standard infant formula; Assigned to Arm(s): Control Group
D: Arm Label: Formula regimen 1; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Formula regimen 1 | Arm Label: Formula regimen 2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Formula regimen 2 | Arm Label: Reference group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Formula regimen 1; Assigned to Arm(s): Formula regimen 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: Formula regimen 2; Assigned to Arm(s): Formula regimen 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Clinical Efficacy of Midline Catheters for Intravenous Therapy: a Randomized, Controlled Study
Brief Summary: The study will evaluate the clinical efficacy of midline catheters compared to conventional treatment in patients with an expected intravenous therapy duration of more than 5 days. Patients will be randomized in a 1:1 ratio. The study will include 120 patient. Endpoints include insertion of CVSs, peripheral venous catheters, catheter patency and a number of possible complications.


Options:
A: Arm Label: echo guidance; Type: EXPERIMENTAL; Interventions: Device: ultrasound guidance and therapeutic communication | Arm Label: conventional; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: ultrasound guidance and therapeutic communication; Assigned to Arm(s): echo guidance
B: Arm Label: PICC-line; Type: ACTIVE_COMPARATOR; Interventions: Device: PICC or subcutaneous venous port | Arm Label: PORT; Type: ACTIVE_COMPARATOR; Interventions: Device: PICC or subcutaneous venous port | Intervention Type: DEVICE; Name: PICC or subcutaneous venous port; Assigned to Arm(s): PICC-line, PORT
C: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Device: Ultrasound-guided peripheral venipuncture | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Device: Conventional peripheral venipuncture | Intervention Type: DEVICE; Name: Ultrasound-guided peripheral venipuncture; Assigned to Arm(s): Intervention group | Intervention Type: DEVICE; Name: Conventional peripheral venipuncture; Assigned to Arm(s): Control group
D: Arm Label: Midline; Type: ACTIVE_COMPARATOR; Interventions: Device: Midline | Arm Label: Conventional; Type: ACTIVE_COMPARATOR; Interventions: Device: PVC and/or PICCline | Intervention Type: DEVICE; Name: PVC and/or PICCline; Assigned to Arm(s): Conventional | Intervention Type: DEVICE; Name: Midline; Assigned to Arm(s): Midline

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Clinical Efficacy of Midline Catheters for Intravenous Therapy: a Randomized, Controlled Study
Brief Summary: The study will evaluate the clinical efficacy of midline catheters compared to conventional treatment in patients with an expected intravenous therapy duration of more than 5 days. Patients will be randomized in a 1:1 ratio. The study will include 120 patient. Endpoints include insertion of CVSs, peripheral venous catheters, catheter patency and a number of possible complications.


Options:
A: Arm Label: Landmark Technique Attempt; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Traditional Landmark Technique (TLT) | Arm Label: USGPIVA Technique Attempt; Type: EXPERIMENTAL; Interventions: Device: ultrasound guided peripheral intravenous access (USGPIVA) | Intervention Type: PROCEDURE; Name: Traditional Landmark Technique (TLT); Assigned to Arm(s): Landmark Technique Attempt | Intervention Type: DEVICE; Name: ultrasound guided peripheral intravenous access (USGPIVA); Assigned to Arm(s): USGPIVA Technique Attempt
B: Arm Label: Easy Access; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound-guided peripheral intravenous access line placement, Procedure: Landmark Approach to peripheral intravenous access line placement | Arm Label: Difficult Access By Clinician Judgment; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound-guided peripheral intravenous access line placement, Procedure: Landmark Approach to peripheral intravenous access line placement | Arm Label: Non visible and Non palpable; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound-guided peripheral intravenous access line placement, Procedure: Landmark Approach to peripheral intravenous access line placement | Intervention Type: PROCEDURE; Name: Ultrasound-guided peripheral intravenous access line placement; Assigned to Arm(s): Difficult Access By Clinician Judgment, Easy Access, Non visible and Non palpable | Intervention Type: PROCEDURE; Name: Landmark Approach to peripheral intravenous access line placement; Assigned to Arm(s): Difficult Access By Clinician Judgment, Easy Access, Non visible and Non palpable
C: Arm Label: Midline; Type: ACTIVE_COMPARATOR; Interventions: Device: Midline | Arm Label: Conventional; Type: ACTIVE_COMPARATOR; Interventions: Device: PVC and/or PICCline | Intervention Type: DEVICE; Name: PVC and/or PICCline; Assigned to Arm(s): Conventional | Intervention Type: DEVICE; Name: Midline; Assigned to Arm(s): Midline
D: Arm Label: Long Axis approach; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Intravenous access method | Arm Label: Short axis approach; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Intravenous access method | Intervention Type: PROCEDURE; Name: Intravenous access method; Assigned to Arm(s): Long Axis approach, Short axis approach

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Physical Activity Intervention for Loneliness (PAIL) in Community-dwelling Older Adults: a Feasibility Study
Brief Summary: The purpose of this study will be to examine the feasibility of a Physical Activity Intervention for Loneliness (PAIL) in community-dwelling older adults. The research is a feasibility study designed as a two-arm randomised controlled trial (RCT) with a wait-list control group (intervention will be offered at 12 weeks to control group).


Options:
A: Arm Label: Stair walking; Type: EXPERIMENTAL; Interventions: Behavioral: Stair walking | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Stair walking | Intervention Type: BEHAVIORAL; Name: Stair walking; Assigned to Arm(s): Control, Stair walking
B: Arm Label: Stair Climbing (SC); Type: EXPERIMENTAL; Interventions: Behavioral: Stair climbing | Arm Label: No Exercise (CON); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Stair climbing; Assigned to Arm(s): Stair Climbing (SC)
C: Arm Label: The experimental group; Type: EXPERIMENTAL; Interventions: Behavioral: Group walking and group educational workshops | Arm Label: The control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Group walking and group educational workshops; Assigned to Arm(s): The experimental group
D: Arm Label: AIT: aerobic interval training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Aerobic interval training | Arm Label: MIT, moderate intensity training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: moderate intensity training | Arm Label: Recommendation of regular exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Recommendation of regular exercise | Intervention Type: BEHAVIORAL; Name: Aerobic interval training; Assigned to Arm(s): AIT: aerobic interval training | Intervention Type: BEHAVIORAL; Name: moderate intensity training; Assigned to Arm(s): MIT, moderate intensity training | Intervention Type: BEHAVIORAL; Name: Recommendation of regular exercise; Assigned to Arm(s): Recommendation of regular exercise

Answer: C